Comorbid conditions commonly affect people with multiple sclerosis (MS). Population-based
studies indicate that people with MS have an increased incidence of ischemic heart disease …

Background Anxiety symptoms and anxiety disorders are prevalent and burdensome, yet
poorly managed in multiple sclerosis (MS). Indeed, anxiety disorders occur in 22% of people …

Objective Vascular comorbidities are associated with reduced cognitive performance and
with changes in brain structure in people with multiple sclerosis (MS). Understanding causal …

Digitalization is changing medicinal services today. A lot of information alludes to Big Data
gathered by digitizing everything. Data accumulated from different sources centers around …

It is important for clinicians to look for possible anxiety disorders among patients with
medical illnesses. Further studies need to ascertain how to best treat individuals suffering …

Comorbidity is highly prevalent in people with multiple sclerosis (MS) throughout their
disease course. In the last 15 years, our understanding of the association between …

There are conflicting findings about the relationships between depression, anxiety, and
cognitive dysfunction in people with multiple sclerosis (MS), and a paucity of research has …

Digital technology has changed health care today. Much data refer to big data collected by
digitizing everything. Information gathered from a variety of sources focuses on changing the …

Objectives: The oral Symbol Digit Modalities Test (SDMT) has become the standard for the
brief screening of cognitive impairment in persons with multiple sclerosis (PwMS). It has …

Multiple sclerosis (MS) is a chronic, inflammatory, degenerative demyelinating disease of
the central nervous system (CNS) of unknown etiology that affects individuals in their early …